Dinesh Raghu
Heidelberg, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancer.
Journal: iScience
Published: December 27, 2023
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
Journal: Science immunology
Published: October 06, 2023
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Journal: Cancers
Published: July 12, 2022
cellCounts: an R function for quantifying 10x Chromium single-cell RNA sequencing data.
Journal: Bioinformatics (Oxford, England)
Published: June 15, 2022
Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease.
Journal: Frontiers in immunology
Published: May 16, 2022
Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1.
Journal: Trends in immunology
Published: July 03, 2019
TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis.
Journal: The Journal of experimental medicine
Published: September 17, 2018
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Journal: Molecular & cellular proteomics : MCP
Published: November 28, 2017
E6AP promotes prostate cancer by reducing p27 expression.
Journal: Oncotarget
Published: February 07, 2017
MDM4 is a rational target for treating breast cancers with mutant p53.
Journal: The Journal of pathology
Published: August 19, 2016
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways.
Journal: Frontiers in oncology
Published: November 18, 2015
Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
Journal: Oncogene
Published: August 27, 2015
Last Updated: 09/26/2026